Golden State Equity Partners »

Leap Therapeutics shares owned by Golden State Equity Partners

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Golden State Equity Partners from 13F filings

Historical chart of Golden State Equity Partners investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Golden State Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Golden State Equity Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $642 250 2.57

More positions owned by Golden State Equity Partners

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Harbor Etf Trust Long Term Grower (WINN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Harbor Etf Trust Long Term Grower (WINN)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exch Traded Fd Iii Horizon Dmst Etf (HUSV)
salesforce (CRM)

View all positions for Golden State Equity Partners

Top funds holding Leap Therapeutics

Balyasny Asset Management
Samsara BioCapital
683 Capital Management
Rock Springs Capital Management
Baker Bros. Advisors
Simplify Asset Management
Vanguard Group
Laurion Capital Management
Citadel Advisors
Geode Capital Management
Key Client Fiduciary Advisors
BlackRock
Acadian Asset Management
BlackRock
Dimensional Fund Advisors

View all funds holding Leap Therapeutics